$139 Million is the total value of Birchview Capital, LP's 63 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 9.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $55,072,000 | +15.3% | 754,106 | -1.6% | 39.65% | +28.7% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $8,366,000 | +10.1% | 89,240 | +0.0% | 6.02% | +22.9% |
| AZYO | AZIYO BIOLOGICS INC | $8,275,000 | -0.9% | 1,417,923 | 0.0% | 5.96% | +10.6% | |
| QDEL | QUIDEL CORP | $6,712,000 | -16.7% | 59,684 | 0.0% | 4.83% | -7.0% | |
| ACAD | ACADIA PHARMACEUTICALS INC | $4,829,000 | +3.8% | 199,400 | 0.0% | 3.48% | +15.9% | |
| FHTX | Sell | FOGHORN THERAPEUTICS INC | $4,480,000 | -37.6% | 294,143 | -6.4% | 3.22% | -30.4% |
| ALBO | ALBIREO PHARMA INC | $3,371,000 | +28.1% | 113,000 | 0.0% | 2.43% | +43.0% | |
| AXDX | ACCELERATE DIAGNOSTICS INC | $3,239,000 | -72.4% | 2,252,388 | 0.0% | 2.33% | -69.2% | |
| UTHR | UNITED THERAPEUTICS CORP | $3,229,000 | -17.0% | 18,000 | 0.0% | 2.32% | -7.3% | |
| CLR | CONTINENTAL RESOURCES INC | $2,367,000 | +37.0% | 38,600 | 0.0% | 1.70% | +53.0% | |
| BIIB | Sell | BIOGEN INC | $2,127,000 | -29.6% | 10,100 | -19.8% | 1.53% | -21.4% |
| BDSX | BIODESIX INC | $2,117,000 | -68.1% | 1,252,753 | 0.0% | 1.52% | -64.3% | |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $1,985,000 | +25.5% | 269,332 | +9.5% | 1.43% | +40.1% |
| OVV | OVINTIV INC | $1,849,000 | +60.4% | 34,200 | 0.0% | 1.33% | +78.9% | |
| BHVN | Buy | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | $1,660,000 | +0.4% | 14,000 | +16.7% | 1.20% | +12.0% |
| PRTA | Buy | PROTHENA CORP PLC | $1,535,000 | -22.8% | 41,978 | +4.3% | 1.10% | -13.8% |
| MASI | Buy | MASIMO CORP | $1,351,000 | -42.3% | 9,280 | +16.0% | 0.97% | -35.6% |
| ALKS | ALKERMES PLC | $1,316,000 | +13.2% | 50,000 | 0.0% | 0.95% | +26.3% | |
| HROW | HARROW HEALTH INC | $1,228,000 | -21.0% | 180,000 | 0.0% | 0.88% | -11.9% | |
| CORT | CORCEPT THERAPEUTICS INC | $1,126,000 | +13.7% | 50,000 | 0.0% | 0.81% | +27.1% | |
| INBX | Buy | INHIBRX INC | $1,124,000 | -35.7% | 50,448 | +26.1% | 0.81% | -28.2% |
| ETRN | EQUITRANS MIDSTREAM CORPORATIO | $1,123,000 | -18.4% | 133,050 | 0.0% | 0.81% | -8.9% | |
| GOSS | Buy | GOSSAMER BIO INC | $1,120,000 | -1.0% | 129,088 | +29.1% | 0.81% | +10.6% |
| Buy | DOCGO INC | $1,018,000 | +983.0% | 110,000 | +1000.0% | 0.73% | +1101.6% | |
| ARVN | ARVINAS INC | $1,010,000 | -18.0% | 15,000 | 0.0% | 0.73% | -8.4% | |
| AMRN | AMARIN CORP PLCspons adr new | $987,000 | -2.4% | 300,000 | 0.0% | 0.71% | +9.0% | |
| PXD | PIONEER NATURAL RESOURCES CO | $950,000 | +37.5% | 3,800 | 0.0% | 0.68% | +53.4% | |
| CYTK | CYTOKINETICS INC | $920,000 | -19.3% | 25,000 | 0.0% | 0.66% | -9.9% | |
| IMGN | IMMUNOGEN INC | $904,000 | -35.9% | 190,000 | 0.0% | 0.65% | -28.4% | |
| PTGX | PROTAGONIST THERAPEUTICS INC | $900,000 | -30.8% | 38,000 | 0.0% | 0.65% | -22.7% | |
| SLNO | Buy | SOLENO THERAPEUTICS INC | $820,000 | +127.8% | 3,676,899 | +319.3% | 0.59% | +154.3% |
| AVEO | AVEO PHARMACEUTICALS INC | $783,000 | +19.2% | 140,000 | 0.0% | 0.56% | +33.0% | |
| CFRX | CONTRAFECT CORP | $730,000 | +38.8% | 200,000 | 0.0% | 0.53% | +55.2% | |
| NARI | Buy | INARI MEDICAL INC | $725,000 | +13.5% | 8,000 | +14.3% | 0.52% | +26.7% |
| NKTR | Buy | NEKTAR THERAPEUTICS | $690,000 | -48.9% | 128,000 | +28.0% | 0.50% | -42.9% |
| IRTC | IRHYTHM TECHNOLOGIES INC | $630,000 | +33.8% | 4,000 | 0.0% | 0.45% | +49.3% | |
| APLS | APELLIS PHARMACEUTICALS INC | $610,000 | +7.6% | 12,000 | 0.0% | 0.44% | +19.9% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $590,000 | +11.5% | 40,000 | 0.0% | 0.42% | +24.6% | |
| Buy | 2SEVENTY BIO INC | $586,000 | -18.4% | 34,333 | +22.6% | 0.42% | -8.9% | |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $566,000 | -39.9% | 50,000 | -16.7% | 0.41% | -32.9% |
| CCXI | CHEMOCENTRYX INC | $501,000 | -31.2% | 20,000 | 0.0% | 0.36% | -23.0% | |
| CGEM | CULLINAN ONCOLOGY INC | $472,000 | -32.2% | 45,114 | 0.0% | 0.34% | -24.3% | |
| SILK | Buy | SILK ROAD MEDICAL INC | $413,000 | +21.1% | 10,000 | +25.0% | 0.30% | +35.0% |
| BLUE | BLUEBIRD BIO INC | $407,000 | -51.5% | 84,000 | 0.0% | 0.29% | -45.8% | |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | $369,000 | -45.1% | 8,000 | 0.0% | 0.27% | -38.6% | |
| FOLD | AMICUS THERAPEUTICS INC | $360,000 | -18.0% | 38,000 | 0.0% | 0.26% | -8.5% | |
| VENTYX BIOSCIENCES INC | $339,000 | -31.8% | 25,000 | 0.0% | 0.24% | -23.8% | ||
| XNCR | XENCOR INC | $328,000 | -33.5% | 12,300 | 0.0% | 0.24% | -25.8% | |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $325,000 | +17.3% | 20,000 | 0.0% | 0.23% | +30.7% | |
| STOK | STOKE THERAPEUTICS INC | $316,000 | -12.2% | 15,000 | 0.0% | 0.23% | -2.2% | |
| GTHX | G1 THERAPEUTICS INC | $304,000 | -25.5% | 40,000 | 0.0% | 0.22% | -16.7% | |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $298,000 | -15.6% | 30,000 | 0.0% | 0.22% | -5.7% | |
| PHR | New | PHREESIA INC | $264,000 | – | 10,000 | +100.0% | 0.19% | – |
| ISEE | IVERIC BIO INC | $252,000 | +0.4% | 15,000 | 0.0% | 0.18% | +11.7% | |
| TPTX | TURNING POINT THERAPEUTICS INC | $215,000 | -43.7% | 8,000 | 0.0% | 0.16% | -37.0% | |
| IFRX | INFLARX NV | $128,000 | -61.6% | 70,000 | 0.0% | 0.09% | -57.2% | |
| ANGN | ANGION BIOMEDICA CORP | $115,000 | -27.2% | 54,392 | 0.0% | 0.08% | -18.6% | |
| AWH | ASPIRA WOMENS HEALTH INC | $107,000 | -41.2% | 103,104 | 0.0% | 0.08% | -34.2% | |
| LSF | Buy | LAIRD SUPERFOOD INC | $101,000 | -57.0% | 28,000 | +55.6% | 0.07% | -52.0% |
| YTEN | YIELD10 BIOSCIENCE INC | $99,000 | +7.6% | 18,750 | 0.0% | 0.07% | +20.3% | |
| SIEN | SIENTRA INC | $89,000 | -39.5% | 40,000 | 0.0% | 0.06% | -32.6% | |
| CNCE | CONCERT PHARMACEUTICALS INC | $67,000 | +6.3% | 20,000 | 0.0% | 0.05% | +17.1% | |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $14,000 | -93.8% | 20,000 | -80.0% | 0.01% | -93.2% |
| TXMD | Exit | THERAPEUTICSMD INC | $0 | – | -50,000 | -100.0% | -0.01% | – |
| PFE | Exit | PFIZER INC | $0 | – | -4,000 | -100.0% | -0.15% | – |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -15,000 | -100.0% | -0.18% | – |
| PGNY | Exit | PROGYNY INC | $0 | – | -15,000 | -100.0% | -0.49% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -22,000 | -100.0% | -1.32% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
| QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
| MASIMO CORP | 36 | Q3 2023 | 2.2% |
| PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
| XENCOR INC | 35 | Q3 2023 | 0.4% |
| NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
| CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
| BIOGEN INC | 31 | Q2 2022 | 3.1% |
| CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
| YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
| YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
| HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
| METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3/A | 2024-02-20 |
| 4/A | 2024-02-20 |
| SC 13G/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-04-07 |
| 4 | 2023-03-27 |
| 3 | 2023-02-13 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.